A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

Background: The efficacy and safety of mometasone furoate aqueous nasal spray (MFNS; Nasonex) 200 μg once daily for the treatment and prophylaxis of seasonal allergic rhinitis (SAR) and treatment of perennial rhinitis have been demonstrated in adults. However, the dose response of MFNS in pediatric...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 1999-07, Vol.104 (1), p.107-114
Hauptverfasser:	Meltzer, Eli O., Berger, William E., Berkowitz, Robert B., Bronsky, Edwin A., Dvorin, Donald J., Finn, Albert F., Galant, Stanley P., Grossman, Jay, Hampel, Frank C., Ratner, Paul H., Ruff, Michael E., Schenkel, Eric J., Segal, Allen T., Segall, Nathan, Stewart, George E., Tripathy, Ita, Skoner, David P., Anolik, Robert, Dockhorn, Robert J., van Bavel, Julius, Mesarina-Wicki, Barbara, Nolop, Keith B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - pharmacokinetics Biological and medical sciences Child Child, Preschool Dose-Response Relationship, Drug Double-Blind Method Drug Tolerance Ent. Stomatology Female Glucocorticoids Humans Male Medical sciences Mometasone Furoate pediatrics Pharmacology. Drug treatments Placebos Pregnadienediols - administration & dosage Pregnadienediols - pharmacokinetics Rhinitis, Allergic, Seasonal - drug therapy Seasonal allergic rhinitis Therapeutic Equivalency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!